What are "indirect costs" for universities? Why are some young scientists looking at opportunities abroad? And why are AI ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

We find diamonds in the rough and we cut and finish them,' Roquefort boss Ajan Reginald says, summing up the company's approach to biotech investment and development.

University is delighted to offer this new opportunity for aspiring doctors from the W Booth School to pursue degrees in medicine with us,' said Dr. Marios Loukas, Dean of St. George's University ...

"I think it's going to be a revolutionary decade in medicine and in clinical research," he said Thursday on "Fox & Friends." "Where AI comes into play is where it's going to allow us to do things ...

They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...

A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...

But local biotech leaders see signs of change in 2025. Amid tough biotech industry market conditions last year, investors and Big Pharma companies were more likely to make deals with later-stage ...

Merck's (NYSE:MRK) recent acquisition of rights to Chinese biotech LaNova Medicines' cancer candidate LM-299 in a deal worth up to $3.3B underscores Big Pharma's appetite for best-in-class assets ...

While 2024 was a “challenging” year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months. On November 28 ...